Close this search box.
Subscriber Log In

Competitive Intelligence Insights: Cell & Gene Therapy


The number of cell and gene therapy (C&GT)-based treatments in development has increased significantly over the last two decades and can be expected to continue, driven by the modality-specific market potential and the breadth of applicability across indications. For competitive intelligence teams tasked with staying on top of this complex and dynamic market, there is […]

Competitive Intelligence and the Quest for the Single Source of Truth


What’s in your competitor’s pipeline? How are their trials progressing? Who is on the cusp of a merger that will increase their funding and how will this impact your business? Continuous monitoring of the market landscape is the bread and butter of a CI professional and you can’t afford to miss anything that may impact […]

CI Meets AI at Pharma CI


Last month saw many of the world’s leading pharma and biotech companies deploy their competitive intelligence (CI) specialists to Newark. Specifically, to the Pharma CI Conference and Exhibition that took place on 20th and 21st of September. I joined them, and it was one of the best iterations of the conference that I’ve been to […]

Latest Forecast: Lots to Discuss on Competitive Intelligence at Pharma CI


Somehow it is already September which means we’re preparing for one of the key events in the biopharma calendar, at least if you’re involved in competitive intelligence – and really, who isn’t? The Pharma CI Conference and Exhibition takes place in Newark on 20th and 21st of September and many of the Evaluate and Norstella […]